Bridge to recovery and the search for decision nodes

Circulation: Heart Failure

Volumn 4, Issue 4, 2011, Pages 393-395

  Yacoub, Magdi H ^a   Terracciano, Cesare M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac myocyte; Contractility; Editorials; Heart assist device; Heart failure; System biology

Indexed keywords

SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1;

CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; NONHUMAN; PRIORITY JOURNAL; REVIEW; DECISION SUPPORT SYSTEM; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; METABOLISM; NOTE; PATHOLOGY; TIME;

CHEMOKINE CXCL12; DECISION SUPPORT TECHNIQUES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MYOCYTES, CARDIAC; TIME FACTORS; VENTRICULAR REMODELING;

EID: 80052788917     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.963058     Document Type: Review

References (14)

1. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Failure. 2011;4:224-233.
2. Ambardekar AV, Walker JS, Walker LA, Cleveland JC Jr, Lowes BD, Buttrick PM. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Failure. 2011;4:425-432.
3. George RS, Yacoub MH, Tasca G, Webb C, Bowles CT, Tansley P, Hardy JP, Dreyfus G, Khaghani A, Birks EJ. Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery. J Heart Lung Transplant. 2007;26:967-973. (Pubitemid 47500147)
4. George RS, Sabharwal NK, Webb C, Yacoub MH, Bowles CT, Hedger M, Khaghani A, Birks EJ. Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds. J Heart Lung Transplant. 2010;29:1245-1252.
5. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J. 2001;22:534-540. (Pubitemid 32625243)
6. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316-2322.. (Pubitemid 28280385)
7. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation. 2004;109:2263-2265. (Pubitemid 38656863)
8. Barton PJ, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation. 2005; 112(Suppl 9):I46-I50. (Pubitemid 41266652)
9. Soppa GK, Lee J, Stagg MA, Siedlecka U, Youssef S, Yacoub MH, Terracciano CM. Prolonged mechanical unloading reduces myofilament sensitivity to calcium and sarcoplasmic reticulum calcium uptake leading to contractile dysfunction. J Heart Lung Transplant. 2008;27:882-889.
10. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res. 2005;96:592-599. (Pubitemid 40463469)
11. Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre- Amione G, Bowles NE, Towbin JA. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet. 2002;359:936-941. (Pubitemid 34246384)
12. Latif N, Yacoub MH, George R, Barton PJ, Birks EJ. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant. 2007;26:230-235. (Pubitemid 46341890)
13. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J. 2007;28:613-627. (Pubitemid 47355497)
14. Egerstedt M. Complex networks: degrees of control. Nature. 2011; 473:158-159.